News

Todd Fehniger, MD, PhD, Professor of Medicine in the Division of Oncology, has been appointed to the Lymphoma Research Foundation’s Scientific Advisory Board. This board comprises experts who guide the foundation’s research agenda and funding priorities. Dr. Fehniger’s extensive experience in lymphoma research will contribute to the foundation’s mission to advance understanding and treatment of […]

Dr. Amanda Cashen, Associate Chief of Hematologic Malignancies and Ramaswamy Govindan, Associate Chief of Oncology, discuss some features of the new Siteman Ambulatory Cancer Center Building. Currently under construction and due to open in the fall of 2024, the new 9-story cancer center is over 657,000 square feet with 4 floors of clinic space to […]

The CheckPoints, a cover band of immunotherapy all-stars, has become a mainstay at the American Society of Clinical Oncology (ASCO) Annual Meeting. Comprised of luminaries in the field of cancer immunotherapy, The CheckPoints perform modern and classic rock hits. Led by Dr. Thomas Gajewski, the band features renowned scientists like Dr. Patrick Hwu, Nobel Prize […]

Dr. Vindigni is the Director of the Center for Genome Integrity and serves as co-leader of the Section of Molecular Oncology in the Division of Oncology. Dr. Vindigni is internationally recognized for his work on DNA replication. He leads one of the few laboratories in the world that integrates electron microscopy approaches with genome-wide single-molecule DNA […]

Brian Van Tine, MD, PhD, Professor of Medicine in the Division of Oncology is the senior author of a clinical trial of CAR-T (chimeric antigen receptor T-cells) cells director against MAGE-A4. 36 of patients with aggressive sarcomas had a tumor response including some patients who entered complete remissions.

The John F. DiPersio Immunotherapy Symposium will take place on Wednesday March 27, 2024. The symposium honors John DiPersio’s contributions to the understanding of the pathogenesis of and development of new treatments for hematopoietic malignancies.   The symposium will feature presentations by three leaders in the field of cancer immunotherapy.  Dr. Stanley Riddell (Fred Hutchinson […]

David DeNardo, Ph.D., is a Professor of Medicine in the Division of Oncology and Co-Director of the Tumor Immunology Program. His work on responses to cancer immunotherapy was recently highlighted on the NCI website. His research team is working to understand why responses to cancer immunotherapy vary among patients. In studying and uncovering mechanisms of […]

Dr. Baggstrom is an ASCO Education Scholar, an associate editor on ASCO’s digital education editorial board, and has served as chair of the organization’s membership advisory committee and on the steering committee of ASCO’s DEI efforts for rising second-year URiM medical students.  The FASCO distinction recognizes members for their extraordinary volunteer service, engagement, dedication, and […]

The Division of Oncology was awarded the highest level of Green Office Certification from the WashU Office of Sustainability. Coordinated by the Office of Sustainability and endorsed by Resource Management, WashU’s Green Office Program aims to encourage offices across all WashU campuses to be champions of the university’s sustainability ethic.

Thomas Odeny, Assistant Professor of Medicine leads the Global Oncology Program in the Division of Oncology. He is the one of the scholars to receive a Robert A. Winn Diversity in Clinical Trials Award. His clinical research grant focuses on expanding clinical trials and treatment options for cancer in underrepresented people living with HIV in […]